Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-06-23
2008-10-21
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S263100, C514S263200, C514S263220, C514S263400, C544S118000, C544S265000, C544S277000, C544S117000, C544S328000, C544S329000, C544S280000, C544S299000, C544S262000
Reexamination Certificate
active
07439240
ABSTRACT:
The present invention therefore provides a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
REFERENCES:
patent: 6921753 (2005-07-01), Mantell et al.
patent: 2002/0132819 (2002-09-01), Metcalf et al.
patent: 2006/0142575 (2006-06-01), Altmann et al.
patent: 1724264 (2006-11-01), None
patent: WO 0055125 (2000-09-01), None
patent: WO 0232879 (2002-04-01), None
patent: 03020278 (2003-03-01), None
patent: WO 03020721 (2003-03-01), None
patent: 2004069256 (2004-08-01), None
patent: 2004076455 (2004-09-01), None
patent: 2005085210 (2005-09-01), None
patent: 2006040300 (2006-04-01), None
International Search Report.
International-Type Search Report.
STN International, CAPLUS accession No. 1991:484886, document No. 115:84886, NAIR, Vasu et al., “Inhibition of mammalian . . . -dideoxyadenosines”, & Biochemica et Biophysica Acta (1991), 1078(1), 121-3.
Database WPI, Week 200136, Derwent Publication Ltd., London, GB; AN 2001-337719 & JP 2001 011037 A (Kissei Yakuhin Kogyo KK), Jan. 16, 2001 Abstract.
Bailey Andrew
Pairaudeau Garry
Patel Anil
Thom Stephen
AstraZeneca AB
Berch Mark L
Shen Jianzhong
LandOfFree
Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4017805